title: Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
authors.forename: Eimantas
authors.initials: E
authors.lastname: Svedas
authors.forename: Romaldas
authors.initials: R
authors.lastname: Maciulaitis
authors.forename: Donatas
authors.initials: D
authors.lastname: Stakisaitis
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000028:Abortion, Induced / Q000331:legislation & jurisprudence; D005260:Female; D033161:Government Regulation; D006801:Humans; D008097:Lithuania; D015735:Mifepristone / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone